Literature DB >> 3877889

A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease.

P J Ell, J M Hocknell, P H Jarritt, I Cullum, D Lui, D Campos-Costa, D P Nowotnik, R D Pickett, L R Canning, R D Neirinckx.   

Abstract

The first clinical data is given on 99Tcm-hexamethylpropyleneamine oxime (HM-PAO) in normal subjects and patients with established stroke. Regional cerebral blood flow maps (rCBF) have been recorded and displayed in tomographic mode with this new radiopharmaceutical. Good images were obtained, comparable to those achieved with 123I-isopropylamphetamine (IMP).

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3877889     DOI： 10.1097/00006231-198508000-00002

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN： 0143-3636            Impact factor:   1.690


  27 in total

1.  Asymptomatic or minimally symptomatic traumatic epidural haematomas: comparison of the results of surgical and conservative management related to SPECT and neuropsychological tests. Preliminary results.

Authors:  S Cayli; E Beşkonakli; E Beştepe; O Okay; S Naldöken; Y Taşkin
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

2.  Establishing brain death: the potential role of nuclear medicine in the search for a reliable confirmatory test.

Authors:  M S George
Journal:  Eur J Nucl Med       Date:  1991

3.  99mTc-hexamethylpropylene amine oxime SPECT and X-ray CT in acute cerebral ischaemia.

Authors:  M Feldmann; E Voth; D Dressler; T Henze; K Felgenhauer
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

4.  Neuroradiological, neurophysiological and anatomopathological study of a case of locked-in syndrome.

Authors:  M Zanardi; M Bonamini; M Rossi
Journal:  Ital J Neurol Sci       Date:  1991-06

Review 5.  The development of new radiopharmaceuticals.

Authors:  K E Britton
Journal:  Eur J Nucl Med       Date:  1990

6.  Clinical experience with Tc-99m HM-PAO high resolution SPECT of the brain in patients with cerebrovascular accidents.

Authors:  M De Roo; L Mortelmans; P Devos; A Verbruggen; G Wilms; H Carton; V Wils; R Van den Bergh
Journal:  Eur J Nucl Med       Date:  1989

7.  A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.

Authors:  H G Gemmell; P F Sharp; J A Besson; K P Ebmeier; F W Smith
Journal:  Eur J Nucl Med       Date:  1988

8.  Semiquantitative assessment of regional cerebral perfusion using 99mTc HM-PAO and emission tomography.

Authors:  G Spreafico; G Gadola; F Cammelli; P Caffarra; A Scaglioni
Journal:  Eur J Nucl Med       Date:  1988

9.  Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.

Authors:  P Colamussi; M Giganti; C Cittanti; L Dovigo; F Trotta; M R Tola; R Tamarozzi; G Lucignani; A Piffanelli
Journal:  Eur J Nucl Med       Date:  1995-01

10.  Evaluation of technetium-99m exametazime stabilised with cobalt chloride as a blood flow tracer in focal cerebral ischaemia.

Authors:  G Gartshore; P Bannan; J Patterson; B Higley; J McCulloch
Journal:  Eur J Nucl Med       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.